
Sign up to save your podcasts
Or
Walgreens officially will go private in a $10 billion deal with private equity firm Sycamore Partners after months of speculation. The Centers for Disease Control and Prevention is on the ground in Texas as the measles outbreak continues to grow. And, Novo Nordisk drops the price of its popular weight loss drug after a similar move from rival drugmaker Eli Lilly. We’ll get those stories—and more—coming up on today’s episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.
4.8
134134 ratings
Walgreens officially will go private in a $10 billion deal with private equity firm Sycamore Partners after months of speculation. The Centers for Disease Control and Prevention is on the ground in Texas as the measles outbreak continues to grow. And, Novo Nordisk drops the price of its popular weight loss drug after a similar move from rival drugmaker Eli Lilly. We’ll get those stories—and more—coming up on today’s episode of the Gist Healthcare podcast.
Hosted on Acast. See acast.com/privacy for more information.
1,276 Listeners
870 Listeners
1,742 Listeners
8,513 Listeners
1,338 Listeners
633 Listeners
112,814 Listeners
56,200 Listeners
1,463 Listeners
468 Listeners
1,073 Listeners
178 Listeners
383 Listeners
5,988 Listeners
143 Listeners